FDA Approved: ETHOSUXIMIDE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ethosuximide from Bionpharma Inc., confirming its use in treating absence seizures associated with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures
• Epilepsy

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

SUPPL AP for ETHOSUXIMIDE (ETHOSUXIMIDE)